The Breast
Volume 19, Issue 2 , Pages 120-127 , April 2010

Effects of guideline adherence in primary breast cancer–A 5-year multi-center cohort study of 3976 patients

  • Achim Wöckel

      Affiliations

    • Department of Gynecology and Obstetrics, University Hospital Ulm, University of Ulm Medical Center, Prittwitzstrasse 43, 89075 Ulm, Germany
    • Corresponding Author InformationCorresponding author. Tel.: +49 (0) 731 500 585 01; fax: +49 (0) 731 500 585 02.
  • ,
  • Christian Kurzeder

      Affiliations

    • Department of Gynecology and Obstetrics, University Hospital Ulm, University of Ulm Medical Center, Prittwitzstrasse 43, 89075 Ulm, Germany
  • ,
  • Verena Geyer

      Affiliations

    • Department of Gynecology and Obstetrics, University Hospital Ulm, University of Ulm Medical Center, Prittwitzstrasse 43, 89075 Ulm, Germany
  • ,
  • Igor Novasphenny

      Affiliations

    • Department of Mathematics and Computer Science, University of Bremen, Germany
  • ,
  • Regine Wolters

      Affiliations

    • Department of Mathematics and Computer Science, University of Bremen, Germany
  • ,
  • Manfred Wischnewsky

      Affiliations

    • Department of Mathematics and Computer Science, University of Bremen, Germany
  • ,
  • Rolf Kreienberg

      Affiliations

    • Department of Gynecology and Obstetrics, University Hospital Ulm, University of Ulm Medical Center, Prittwitzstrasse 43, 89075 Ulm, Germany
  • ,
  • Dominic Varga

      Affiliations

    • Department of Gynecology and Obstetrics, University Hospital Ulm, University of Ulm Medical Center, Prittwitzstrasse 43, 89075 Ulm, Germany

Received 26 July 2009 ,Revised 12 December 2009 ,Accepted 14 December 2009.

References 

  1. Giersiepen K, Heitmann C, Janhsen K, Lange C. In: Brustkrebs. Gesundheitsberichterstattung des Bundes. Robert-Koch-Institut; 2005;Issue 25
  2. Statistisches Bundesamt Deutschland. http://www.destatis.de/jetspeed/portal/search/results.psml
  3. Kreienberg R For the German cancer Society. Interdisziplinäre S 3-Leitlinie für die Diagnostik und therapie des Mammakarzinoms der Frau. Munich: Zuckschwerdt Verlag; 2004;
  4. Lorenz W, Ollenschläger G, Geraedts M, Gerlach F, Gangjour A, Helou A, et al. Guideline developement. German J Evid Med. 2001;95:1–84
  5. Kopp I for the German Cancer Society. Methodenreport zur S3-Leitlinie “Diagnostik, therapie und Nachsorge des Mammakarzinoms. Munich: Zuckschwerdt Verlag; 2008;
  6. Europarat . Entwicklung einer Methodik für die Ausarbeitung von Leitlinien für optimale medizinische Praxis. Empfehlung Rec (2001) 13 des Europarates und Erläuterndes Memorandum. German Edition. Z Arztl Fortbild Qualitatssich. 2002;96:1–60
  7. Black N, Murphy M, Lamping D, McKee M, Sanderson C, Askham J, et al. Consensus development methods: a review of best practice in creating clinical guidelines. J Health Serv Res Policy. 1999;4:236–248
  8. Delbecq AL, Van de Ven AH, Gustafson DH. Group techniques for program planning. Glenview, IL: Scott, Foresman and Company; 1975;
  9. Scottish Intercollegiate Guidelines Network . A Guideline developers handbook. SIGN publication No. 50. http://www.sign.ac.uk/guidelines/fulltext/50/index.html.-2001;[Accessed 1 2007]
  10. Brucker SY, Schumacher C, Sohn C, Rezai M, Bamberg M, Wallwiener D, et al. Benchmarking the quality of breast cancer care in a nationwide voluntary system: the first five-year results (2003-2007) from Germany as a proof of concept. BMC Cancer. 2008;8:358–364
  11. Schmidt M, Victor A, Bratzel D, Boehm D, Cotarelo C, Lebrecht A, et al. Long-term outcome prediction by clinicopathological risk classification algorithms in node-negative breast cancer–comparison between Adjuvant!, St Gallen, and a novel risk algorithm used in the prospective randomized Node-Negative-Breast Cancer-3 (NNBC-3) trial. Ann Oncol. 2008;29
  12. Lee AH, Ellis IO. The Nottingham prognostic index for invasive carcinoma of the breast. Pathol Oncol Res. 2008;14:113–115
  13. Schwamm LH, Fonarow GC, Reeves MJ, Pan W, Frankel MR, Smith EE, et al. Get with the guidelines-stroke is associated with sustained improvement in care for patients hospitalized with acute stroke or transient ischemic attack. Circulation. 2008;15
  14. Van der Wel M, Bakx C, de Grauw W, van Gerwen W, Mulder J, van Weel C. The influence of guideline revisions on the process and outcome of hypertension management in general practice: a descriptive study. Eur J Gen Pract. 2008;14:47–52
  15. Hamaker ME, Schreurs WH, Uppelschoten JM, Smorenburg CH. Breast cancer in the elderly: retrospective study on diagnosis and treatment according to national guidelines. Breast J. 2009;15:26–33
  16. Hebert-Croteau N, Brisson J, Latreille J, Rivard M, Abdelaziz N, Martin G. Compliance with consensus recommendations for systemic therapy is associated with improved survival of women with node-negative breast cancer. J Clinical Oncology. 2004;22:3685–3693
  17. Dressler LG, Berry DA, Broadwater G, Cowan D, Cox K, Griffin S, et al. Comparison of HER2 status by fluorescence in situ hybridization and immunohistochemistry to predict benefit from dose escalation of adjuvant doxorubicin-based therapy in node-positive breast cancer patients. J Clin Oncol. 2005;19:4287–4297
  18. Hakkennes S, Dodd K. Guideline implementation in allied health professions: a systematic review of the literature. Qual Saf Health Care. 2008;17:296–300
  19. Fernandez RS, Davidson P, Griffiths R. Cardiac rehabilitation coordinators' perceptions of patient-related barriers to implementing cardiac evidence-based guidelines. J Cardiovasc Nurs. 2008;23:449–457
  20. Weinert CR, Mann HJ. The science of implementation: changing the practice of critical care. Curr Opin Crit Care. 2008;14:460–465
  21. Vitry AI, Zhang Y. Quality of Australian clinical guidelines and relevance to the care of older people with multiple comorbid conditions. Med J Aust. 2008;189:360–365

PII: S0960-9776(09)00178-7

doi: 10.1016/j.breast.2009.12.006

The Breast
Volume 19, Issue 2 , Pages 120-127 , April 2010